28 April 2016

Interim report for the first quarter of 2016:

Bayer off to a successful start in 2016

Substantial sales growth at Pharmaceuticals / Earnings expand in all segments / Group sales increase to EUR 11,941 million (plus 0.5 percent / Fx & portfolio adj. plus 3.2 percent) / EBITDA before special items advances by 15.7 percent to EUR 3,404 million / EBIT up 20.1 percent to EUR 2,335 million / Net income grows by 13.3 percent to EUR 1,511 million / Core earnings per share up 13.9 percent to EUR 2.37 / Outlook for 2016 confirmed

 

 

 

Read more: http://www.news.bayer.com/baynews/baynews.nsf/id/Bayer-off-to-a-successful-start-in-2016